# ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
Canonical URL: https://biopharmsignal.com/news/ICUI/icu-medical-announces-time-of-second-quarter-2026-earnings-conference-call-20153c86
Ticker: ICUI
Company: ICU Medical
Source: ICU Medical
Published: 2026-07-23 12:30 EST
## Summary

ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative...

## Article Body
ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2026 earnings release and conference call.

The Company will release its second quarter 2026 results on Thursday, August 6, 2026 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, August 6, 2026. The call can be accessed at 1-800-420-1459, conference ID “ICUMED”. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com , clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.

About ICU Medical

ICU Medical (Nasdaq: ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com .

CONTACT: ICU Medical, Inc. Brian Bonnell, Chief Financial Officer (949) 366-2183

ICR, Inc. John Mills, Managing Partner (646) 277-1254

Source: ICU Medical, Inc.
## Recent Company News
- 2026-07-23 12:30 EST — [ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call](https://biopharmsignal.com/news/ICUI/icu-medical-announces-time-of-second-quarter-2026-earnings-conference-call-20153c86) — Source: ICU Medical
- 2026-05-07 20:05 EST — [ICU Medical Announces First Quarter 2026 Results](https://biopharmsignal.com/news/ICUI/icu-medical-announces-first-quarter-2026-results-5829e642) — Source: ICU Medical
- 2026-04-23 12:30 EST — [ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call](https://biopharmsignal.com/news/ICUI/icu-medical-announces-time-of-first-quarter-2026-earnings-conference-call-6e434179) — Source: ICU Medical
- 2026-02-23 13:30 EST — [ICU Medical to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/ICUI/icu-medical-to-participate-in-upcoming-investor-conferences-7eb475f2) — Source: ICU Medical
- 2026-02-19 21:05 EST — [ICU Medical Announces Fourth Quarter 2025 Results and Provides Fiscal Year 2026 Guidance](https://biopharmsignal.com/news/ICUI/icu-medical-announces-fourth-quarter-2025-results-and-provides-fiscal-year-2026--0e1ae898) — Source: ICU Medical
## Related News
- 2026-07-28 13:00 EST — ENLV — [Enlivex Announces $400,000,000 Private Placement](https://biopharmsignal.com/news/ENLV/enlivex-announces-400-000-000-private-placement-20e71a7a)
- 2026-07-28 12:30 EST — XRAY — [Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship](https://biopharmsignal.com/news/XRAY/dentsply-sirona-advances-commercial-growth-strategy-in-canada-through-expanded-m-e2440bb2)
- 2026-07-28 12:30 EST — RLMD — [Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-appoints-uro-oncology-leader-bipin-dalmia-as-chief-business-5c4d7b11)
- 2026-07-28 12:05 EST — RIGL — [Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/RIGL/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2026-financ-5b987d7a)
- 2026-07-28 12:05 EST — GSK — [GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UK](https://biopharmsignal.com/news/GSK/gsk-to-establish-new-flagship-r-d-centre-on-cambridge-biomedical-campus-uk-6f2bb859)